Blood Glucos Monitoring

Press Releases

Abbott’s FreeStyle Libre® 3 Receives U.S. FDA Clearance – Features World’s Smallest, Thinnest and Most Accurate 14-Day Glucose Sensor

Abbott (NYSE: ABT) today announced the U.S. Food and Drug Administration (FDA) cleared its next-generation FreeStyle Libre 3 system for use by people four years and older6 living with diabetes. “The FreeStyle Libre 3 system is a direct result of listening to our customers – and giving them the innovation and sensing technology they’ve been looking for,” said Jared Watkin, senior vice president of Abbott’s…